An orally bioavailable sulfated oligosaccharide derivative that inhibits human immunodeficiency virus in vitro and provides sustainned drug level in mammals with low-anticoagulant activity: T. Shoji1, H. Nakashima2, A. Kasai1, M. Iiyama1, N. Takahashi1, K. Inazawa2, K. Ichiyama2, M. Ito2, N. Yamamoto1 and R.F. Schinazi4 1Central Research Laboratotries, Dainippon Ink & Chemicals, Inc. 631 Sakado, Sakura-shi, Chiba, 285 Japan; 2Department of Microbiology, Yamanashi Medical University, Yamanashi, Japan; 3Department of Microbiology, School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan; 4Veterans Affairs Medical Center and Department of Pediatrics, Laboratory of Biochemical Pharmacology, Emory University School of Medicine, Decatur, Georgia, 30033, USA